Is there a suitable way to purchase genuine Amivantamab?

Introduction: Amivantamab is a fully human bispecific antibody targeting EGFR and MET. It has been approved in the United States and other countries for the treatment of patients with advanced NSCLC with EGFR exon 20 insertion mutations whose disease has progressed during or after platinum-based chemotherapy. Preliminary efficacy and safety have also been confirmed in patients with common EGFR or MET mutated NSCLC.

Is there a suitable way to purchase genuine Amivantamab

's trade name is Rybrevant. It is an EGFR/c-Met bispecific antibody therapy for the treatment of non-small cell lung cancer. You can refer to the following purchasing methods

1. Hospital pharmacy: Amivantumab is currently on the market in Hong Kong, China. Patients can go to hospitals in Hong Kong, China. After the doctor issues a medical prescription, they can purchase Amivantumab directly in the hospital pharmacy.

2. Regular pharmacies: You can purchase evantumumab in pharmacies in Hong Kong, China. You can go to a large local pharmacy to inquire whether you can buy evantumumab.

3. Overseas drug purchase: Patients can go to countries where evantumumab is already on the market to purchase it. They may buy the exported Turkish version or other exported versions of evantumumab.

4. Medical service institutions: There are some domestic medical service institutions that cooperate with foreign pharmaceutical companies or hospitals and may provide medical services such as global drug search and drug purchase. You can inquire whether you can buy evantumumab.

5. Clinical trials: Evantumumab is undergoing multiple clinical trials, and patients may have the opportunity to obtain the drug by participating in clinical trials.

The purchase and use of evantumumab should always be done under the guidance of a doctor to ensure the safety and effectiveness of the treatment. At the same time, patients need to undergo regular examinations and monitoring to ensure the safety and effectiveness of the drug, and to understand in a timely manner.

Side effects of Amivantumab

1. Skin reactions: including rash, itching, dryness and other adverse skin reactions.

2. Gastrointestinal reactions: may include nausea, vomiting, diarrhea and other gastrointestinal discomfort symptoms.

3. Immune-related adverse reactions: immune-related adverse reactions such as immune hepatitis and pneumonia may occur.

4. Blood system adverse reactions: Anemia, thrombocytopenia and other blood system adverse reactions may occur.

5. Infusion-related reactions: Reactions that may occur during the infusion process require the infusion to be interrupted at the first sign, and the infusion rate to be reduced or the use of evantumumab to be permanently terminated depending on the severity.

Recommended dose of evantumumab

The recommended dose of evantumumab is adjusted according to the patient's baseline weight. The recommended dose for patients weighing <80kg is 1050mg, and the recommended dose for patients weighing ≥80kg is 1400mg. The drug is administered by intravenous infusion and requires appropriate dilution before use.

Patients should pay close attention to their physical condition when using evantumumab and promptly report any symptoms of discomfort to their doctor so that the treatment plan can be adjusted in a timely manner. At the same time, women with potential fetal reproductive risks are advised to use an effective method of contraception as evantumumab may have embryo-fetal toxicity.